Published in
American Association for the Advancement of Science, Science Translational Medicine, 527(12), 2020
DOI: 10.1126/scitranslmed.aax3772
Links
Tools
PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma
Journal article published in 2020 by
Xiaochao Tan 
,
Priyam Banerjee ,
Edward A. Pham ,
Florentine U. N. Rutaganira ,
Kaustabh Basu,
Neus Bota-Rabassedas,
Hou-Fu F. Guo ,
Caitlin L. Grzeskowiak,
Xin Liu,
Jiang Yu,
Lei Shi ,
David H. Peng ,
B. Leticia Rodriguez,
B. Leticia Rodriguez ,
Jiaqi Zhang
and other authors.
,
Priyam Banerjee ,
Edward A. Pham ,
Florentine U. N. Rutaganira ,
Kaustabh Basu,
Neus Bota-Rabassedas,
Hou-Fu F. Guo ,
Caitlin L. Grzeskowiak,
Xin Liu,
Jiang Yu,
Lei Shi ,
David H. Peng ,
B. Leticia Rodriguez,
B. Leticia Rodriguez ,
Jiaqi Zhang
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
This study identifies a molecular basis for malignant secretion and provides a rationale to test PI4KIIIβ antagonists as an intervention.